RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Cervical Cancer Therapy Area Pipeline Report
Nov 2010 - 146 pages - $1,495
Stakeholder Opinions: Cervical and Endometrial Cancer - Opportunities remain outside the big gynecologic malignancies
Mar 2010 - 101 pages - $3,800
Cervical Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Dec 2010 - 49 pages - $2,000
Pipeline Insight: Cancer Overview- Breast and Gynecological Cancers - Promising agents emerge for BRCA positive patients
Jan 2011 - 266 pages - $11,400
Cervical Cancer Global Clinical Trials Review, Q4, 2010
Oct 2010 - 66 pages - $1,000
Epidemiology: Cervical Cancer - The small decrease in cervical cancer cases over the next decade in the seven major markets is driven by decreasing incidence rates
Feb 2011 - 33 pages - $5,700
Cervical Cancer Global Clinical Trials Review, H2, 2011
Aug 2011 - 121 pages - $1,000
Successes and Failures for Avastin (Bevacizumab) mean Mixed News for the Blockbuster Drug in the Oncology Therapeutics Market
May 2011 - 7 pages - $500
US Oncology, Inc. - SWOT Analysis
Nov 2010 - 26 pages - $125
Biomarkers in Cancer Research - High Unmet Need in Cervical Cancer and Lung Cancer to Drive Growth
Sep 2010 - 78 pages - $3,500
More Related Market Research Reports >>>

Your selection

Industry sector
Pharmaceutical del
Therapeutic target
Oncology del
Cervical cancer del
Development phase
Early Stage del

Browse By

Industry sector
Generics
Nutrition
OTC/Non-Prescription
Pediatric
Personal Care
Prescription
Therapeutic target
Adenocarcinoma

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us